Evidence map›Paper›PMID 23559893›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2011

Assessment of cognition in early dementia.

Nina B Silverberg, Laurie M Ryan, Maria C Carrillo, Reisa Sperling, Ronald C Petersen, Holly B Posner, Peter J Snyder, Robin Hilsabeck, Michela Gallagher, Jacob Raber and 24 more

Open access · greenAbstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Observational
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 1 country.

Nina B SilverbergDivision of Neuroscience, National Institute on Aging, National Institutes of Health, Bethesda MD.
Laurie M Ryan
Maria C Carrillo
Reisa Sperling
Ronald C Petersen
Holly B Posner
Peter J Snyder
Robin Hilsabeck
Michela Gallagher
Jacob Raber
Albert Rizzo
Katherine Possin
Jonathan King
Jeffrey Kaye
Brian R Ott
Marilyn S Albert
Molly V Wagster
John A Schinka
C Munro Cullum
Sarah T Farias
David Balota
Stephen Rao
David Loewenstein
Andrew E Budson
Jason Brandt
Jennifer J Manly
Lisa Barnes
Adriana Strutt
Tamar H Gollan
Mary Ganguli
Debra Babcock
Irene Litvan
Joel H Kramer
Tanis J Ferman
National Institutes of Health · USJohns Hopkins University · USBrown University · USOregon Health & Science University · USUniversity of California, San Francisco · USAlzheimer's Association · USBaylor College of Medicine · USBrigham and Women's Hospital · USCleveland Clinic · USColumbia University Irving Medical Center · USCreative Technologies (United States) · USEdith Nourse Rogers Memorial Veterans Hospital · USJames A. Haley Veterans' Hospital · USMayo Clinic in Arizona · USMayo Clinic in Florida · USMount Sinai Medical Center · USNational Institute on Aging · USPfizer (United States) · USRush University Medical Center · USSouth Texas Veterans Health Care System · US

Funding

Intramural NIH HHS Z99 AG999999NIA NIH HHS R99 AG999999
6 · The paper itself

Abstract

Better tools for assessing cognitive impairment in the early stages of Alzheimer's disease (AD) are required to enable diagnosis of the disease before substantial neurodegeneration has taken place and to allow detection of subtle changes in the early stages of progression of the disease. The National Institute on Aging and the Alzheimer's Association convened a meeting to discuss state of the art methods for cognitive assessment, including computerized batteries, as well as new approaches in the pipeline. Speakers described research using novel tests of object recognition, spatial navigation, attentional control, semantic memory, semantic interference, prospective memory, false memory and executive function as among the tools that could provide earlier identification of individuals with AD. In addition to early detection, there is a need for assessments that reflect real-world situations in order to better assess functional disability. It is especially important to develop assessment tools that are useful in ethnically, culturally and linguistically diverse populations as well as in individuals with neurodegenerative disease other than AD.

Identifiers

PMID23559893
PMCPMC3613863
OpenAlexW2000540030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.